Dr Nick Larkins, from Edith Cowan University's (ECU's) School of Medical and Health Sciences, has been awarded a total of $148,162 in grant funding from the Heart Foundation to carry out cardiovascular research.
The Vanguard Grant is a highly competitive funding initiative which was awarded to only 24 researchers across Australia this year. Vanguard research projects are exploratory in nature, testing the feasibility of research projects which may lead to tangible outcomes, and larger and more rigorous studies further down the track. The aim is to develop research technology in order to improve cardiovascular health.
One in four Australian lives is lost to heart disease every year. The Heart Foundation, the largest non-government heart funding provider for research into heart disease in Australia, supports cardiovascular research through its extensive donor scheme.
Heart Foundation research awards total $14.5 million in 2026, supporting work towards preventing, detecting and treating heart disease. Sixty-seven projects were funded in all this year.
Dr Larkins' project, entitled 'The GenPressure Trial: When & whether to screen children's blood pressure', concerns high blood pressure in children. It has shown that one in 11 Australian children has high blood pressure, often caused by lifestyle factors, and he was instrumental in developing Australia's first ever clinical guidelines on childhood hypertension.
The Vanguard project will work to test the real-world implementation of population-level school-based blood pressure screening.
"The HF Vanguard Grant gives us the boost needed to make the GenPressure Trial a reality, answering important short-term implementation and feasibility questions, while establishing funding for the broader trial," Dr Larkins said.
He explained that project has only been made possible by multiple unique events coming together, including the development of a recent national guideline and the statewide cohort of children being researched now approaching school age.
"The outcomes from GenPressure will be unique not only in the Australian but also broader global context, with no such trial ever having been performed at scale previously."
The Vanguard Grant shows the impact of world-class ECU research, which is directly contributing to real-world benefits and driving progress towards better health outcomes for all Australians.
Dr Larkin's project concerns screening for high blood pressure in children.